315 related articles for article (PubMed ID: 29361103)
1. Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
Rao BB; Lashner B; Kowdley KV
Inflamm Bowel Dis; 2018 Jan; 24(2):269-276. PubMed ID: 29361103
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
3. Clinical management of inflammatory bowel disease in the organ recipient.
Indriolo A; Ravelli P
World J Gastroenterol; 2014 Apr; 20(13):3525-33. PubMed ID: 24707135
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease in liver transplanted patients.
Filipec Kanizaj T; Mijic M
World J Gastroenterol; 2017 May; 23(18):3214-3227. PubMed ID: 28566881
[TBL] [Abstract][Full Text] [Related]
5. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study.
Jørgensen KK; Lindström L; Cvancarova M; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
Scand J Gastroenterol; 2012 Sep; 47(8-9):1021-9. PubMed ID: 22577871
[TBL] [Abstract][Full Text] [Related]
6. Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis.
Singh S; Edakkanambeth Varayil J; Loftus EV; Talwalkar JA
Liver Transpl; 2013 Dec; 19(12):1361-9. PubMed ID: 24019127
[TBL] [Abstract][Full Text] [Related]
7. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update.
Rossi RE; Conte D; Massironi S
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):123-31. PubMed ID: 26636407
[TBL] [Abstract][Full Text] [Related]
8. Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.
Peverelle M; Paleri S; Hughes J; De Cruz P; Gow PJ
Inflamm Bowel Dis; 2020 Nov; 26(12):1901-1908. PubMed ID: 31944235
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.
Palmela C; Peerani F; Castaneda D; Torres J; Itzkowitz SH
Gut Liver; 2018 Jan; 12(1):17-29. PubMed ID: 28376583
[TBL] [Abstract][Full Text] [Related]
10. Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report.
Åberg F; Abdulle A; Mäkelä A; Nissinen M
Transplant Proc; 2015 Nov; 47(9):2775-7. PubMed ID: 26680092
[TBL] [Abstract][Full Text] [Related]
11. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF
Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821
[TBL] [Abstract][Full Text] [Related]
12. Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature.
Wang R; Leong RW
World J Gastroenterol; 2014 Jul; 20(27):8783-9. PubMed ID: 25083052
[TBL] [Abstract][Full Text] [Related]
13. Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis.
Singh S; Khanna S; Pardi DS; Loftus EV; Talwalkar JA
Inflamm Bowel Dis; 2013 Jul; 19(8):1631-8. PubMed ID: 23665966
[TBL] [Abstract][Full Text] [Related]
14. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
de Vries AB; Janse M; Blokzijl H; Weersma RK
World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
[TBL] [Abstract][Full Text] [Related]
15. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
[TBL] [Abstract][Full Text] [Related]
16. Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis.
Sokol H; Cosnes J; Chazouilleres O; Beaugerie L; Tiret E; Poupon R; Seksik P
World J Gastroenterol; 2008 Jun; 14(22):3497-503. PubMed ID: 18567077
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series.
Altwegg R; Combes R; Laharie D; De Ledinghen V; Radenne S; Conti F; Chazouilleres O; Duvoux C; Dumortier J; Leroy V; Treton X; Durand F; Dharancy S; Nachury M; Goutorbe F; Lamblin G; Boivineau L; Peyrin-Biroulet L; Pageaux GP
Dig Liver Dis; 2018 Jul; 50(7):668-674. PubMed ID: 29655972
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Singh S; Loftus EV; Talwalkar JA
Am J Gastroenterol; 2013 Sep; 108(9):1417-25. PubMed ID: 23896954
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]